Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy

[en] OBJECTIVE- Insulin resistance may be a risk factor for diabetic microangiopathy, which may have a familial component. We carried out a family-based study to determine which components of the insulin resistance syndrome are associated with diabetic retinopathy and nephropathy in type 1 diabetes. RESEARCH DESIGN AND METHODS- The Genesis France-Belgium Study is a multicenter binational study designed to investigate the genetic factors involved in the microvascular complications of type 1 diabetes using a family-based design. Probands were type 1 diabetic patients with diabetic retinopathy (classified as background, preproliferative, or proliferative) and possibly diabetic nephropathy (absent, incipient, established, or advanced). The insulin resistance score of their first-degree relatives was calculated according to their BMI and history of arterial hypertension, lipid disorders, and type 2 diabetes. RESULTS- The insulin resistance score of relatives was positively correlated with the albumin excretion rate (P = 0.0009) and fasting plasma glucose (P = 0.0003) and HbA(1c) (P < 0.0001) concentrations. This score was higher in the relatives of probands with than in those without diabetic nephropathy (P = 0.0370). Similarly, it was higher in relatives of subjects with proliferative diabetic retinopathy than in those of probands without, even after controlling for subjects with versus without diabetic nephropathy (P = 0.0379). However, the components of the insulin resistance score in relatives differed according to the severity of diabetic retinopathy or nephropathy in the probands. Obesity and history of arterial hypertension were most common in relatives of probands with proliferative diabetic retinopathy, whereas obesity and history of lipid disorders were most common in the relatives of probands with diabetic nephropathy. CONCLUSIONS- Familial insulin resistance segregates with diabetic complications: lipid disorders and obesity segregate with diabetic nephropathy, whereas arterial hypertension and obesity segregate with diabetic retinopathy.

Disciplines :

Endocrinology, metabolism & nutrition

Author, co-author :

Hadjadj, S.

Pean, F.

Gallois, Y.

Passa, P.

Aubert, R.

Weekers, Laurent ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie

Rigalleau, V.

Bauduceau, B.

Bekfierraz, A.

More authors (6 more)

Language :

English

Title :

Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy

Publication date :

November 2004

Journal title :

Diabetes Care

ISSN :

0149-5992

eISSN :

1935-5548

Publisher :

American Diabetes Association, Alexandria, U.S. Virgin Islands

Volume :

Issue :

Pages :

2661-2668

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 18 August 2010

Statistics

Number of views

49 (0 by ULiège)

Number of downloads

235 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Klein R, Klein BE, Jensen SC, Moss SE: The relation of socioeconomic factors to the incidence of proliferative diabetic retinopathy and loss of vision. Ophthalmology 101:68-76, 1994
Rossing P, Hougaard P, Borch-Johnsen K, Parving H-H: Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ 313:779-784, 1996
Borch-Johnsen K, Kreimer S: Proteinuria: value as predictor of cardio-vascular mortality in insulin-dependent diabetes. BMJ 294:1651-1654, 1987
Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving HH: Is diabetic nephropathy an inherited complication? Kidney Int 41:719-722, 1992
Rogus JL, Krolewski AJ: Using discordant sib pairs to map loci for qualitative traits with high sibling recurrence risk. Am J Hum Genet 59:1376-1381, 1996
Tarnow L, Rossing P, Nielsen FS, Fagerudd JA, Poirier O, Parving HH: Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy. Diabetes Care 23:30-33, 2000
Earle K, Walker J, Hill C, Viberti G: Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 326:673-677, 1992
Barzilay J, Warram JH, Bak M, Laffel LM, Canessa M, Krolewski AS: Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM. Kidney Int 41:723-730, 1992
Freire MB, Ferreira SR, Vivolo MA, Oliveira JM, Zanella MT: Familial hypertension and albuminuria in normotensive type I diabetic patients. Hypertension 23:1256-1258, 1994
Fagerudd JA, Tarnow L, Jacobsen P, Stenman S, Nielsen FS, Pettersson-Fernholm KJ, Gronhagen-Riska C, Parving H-H, Groop P-H: Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients. Diabetes 47:439-444, 1998
Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC: Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-depndent) diabetes mellitus. Diabetologia 33:438-443, 1990
Rema M, Saravanan G, Deepa R, Mohan V: Familial clustering of diabetic retinopathy in South Indian type 2 diabetic patients. Diabet Med 19:910-916, 2002
The Diabetes Control and Complications Trial Research Group: Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 46:1829-1839, 1997
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 285:2486-2497, 2001
Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
Mathiesen ER, Ronn B, Jensen T, Storm B, Decken T: The relationship between blood pressure and urinary albumin excretion in the development of microalbuminuria. Diabetes 39:245-249, 1990
Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL: Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. Kidney Int 64:817-828, 2003
Fagerudd JA, Pettersson-Fernholm KJ, Gronhagen-Riska C, Groop PH: The impact of a family history of type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with type I (insulin-dependent) diabetes mellitus. Diabetologia 42:519-526, 1999
Zhang L, Krzentowski G, Albert A, Lefebvre PJ: Factors predictive of nephropathy in DCCT type 1 diabetic patients with good or poor metabolic control. Diabet Med 20:580-585, 2003
Zhang L, Krzentowski G, Albert A, Lefebvre PJ: Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 24:1275-1279, 2001
Chaturvedi N: Differing aspects of insulin resistance in diabetes complications: the shape of things to come: RD Lawrence Lecture 2000. Diabet Med 19:973-977, 2002
The Expert Comittee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Comittee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
Chaturvedi N, Sjoelie AK, Porta M, Aldington SJ, Fuller JH, Songini M, Kohner EM: Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care 24:284-289, 2001
Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE: Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 62:963-970, 2002
Yip J, Mattock M, Sehti M, Morocutti A, Viberti G: Insulin resistance in family members of insulin-dependent diabetic patients with micoalbuminuria. Lancet 341:369-370, 1993
Verhage B, Vervoort G, Wolkotte C, Elving LD, Wetzels JF, Willems H, Smits P, Verbeek AL, Berden JH: Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy. Diabetes Care 22:1048-1052, 1999
De Cosmo S, Bacci S, Piras GP, Cignarelli M, Placentino G, Margaglione M, Colaizzo D, Di Minno G, Giorgino R, Liuzzi A, Viberti GC: High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria. Diabetologia 40:1191-1196, 1997
Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F: Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 99:1585-1595, 1997
Kohner EM: The lesions and natural history of diabetic retinopathy. In Textbook of Diabetes. Pickup J, Williams G, Eds. Oxford, U.K. Blackwell Scientific, 1991, p. 575-588
Bauduceau B, Chatellier G, Cordonnier D, Marre M, Mimran A, Monnier L, Sauvanet J-P, Valensi P, Balarac N: Arterial hypertension and diabetes: members of the Board of Directors and Scientific Directors of ALFEDIAM. Diabetes Metab 22:64-76, 1996
Marre M, Claudel JP, Ciret P, Luis N, Suarez L, Passa P: Laser immunonephelometry for routine quantification of urinary albumin excretion. Clin Chem 33:209-213, 1987
Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
Armitage P, Berry G: Components of χ2. In Statistical Methods in Medical Research. Blackwell Scientific, Oxford, U.K., 1990, p. 469-472
Osei K, Rhinesmith S, Gaillard T, Schuster D: Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in non-diabetic, first-degree relatives of African-American patients with type 2 diabetes? J Clin Endocrinol Metab 88:4596-4601, 2003
Forsblom CM, Eriksson JG, Ekstrand AV, Teppo AM, Taskinen MR, Groop LC: Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetologia 38:363-369, 1995
Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, LaPorte RE, Kuller LH: Prevalence in complications in IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39:1116-1124, 1990
The EURODIAB IDDM Complications Study Group: Microvascular and acute complications in IDDM subjects: the EURODIAB IDDM Complications Study. Diabetologia 37:278-285, 1994
Asmar R, Pannier B, Vol S, Brisac AM, Tichet J, el Hasnaoui A: Cardiovascular risk factors in France: prevalence and association. Arch Mal Coeur Vaiss 95:239-245, 2002
Balkau B, Vernay M, Mhamdi L, Novak M, Arondel D, Vol S, Tichet J, Eschwege E: The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome: the French D.E.S.I.R. study. Diabetes Metab 29:526-532, 2003
Herrmann SM, Ringel J, Wang JG, Staessen JA, Brand E: Peroxisome proliferator-activated receptor-γ2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: the Berlin Diabetes Mellitus (BeDiaM) Study. Diabetes 51:2653-2657, 2002
Canani LH, Ng DP, Smiles A, Rogus JJ, Warram JH, Krolewski AS: Polymorphism in ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 diabetes. Diabetes 51:1188-1193, 2002
Norgaard K, Mathiesen ER, Hommel E, Jensen JS, Parving HH: Lack of familial predisposition to cardiovascular disease in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 34:370-372, 1991
Taverna MJ, Sola A, Guyot-Argenton C, Pacher N, Bruzzo F, Chevalier A, Slama G, Reach G, Selam JL: eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy. Diabet Mid 19:240-245, 2002
Lindsay RS, Little J, Jaap AJ, Padfield PL, Walker JD, Hardy KJ: Diabetic nephropathy is associated with an increased familial risk of stroke. Diabetes Care 22:422-425, 1999
Jones SF, Close CF, Mattock MB, Jarret RJ, Keen H, Viberti G: Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ 298:487-490, 1989
Hadjadj S, Gallois Y, Simard G, Bouhanick B, Passa P, Grimaldi A, Drouin P, Tichet J, Marre M: Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein: Genetique de la Nephropathie Diabetique Study Group: Donnees Epidemiologiques sur le Syndrome D'Insulino-Resistance Study Group. Nephrol Dial Transplant 15:1971-1976, 2000
Chaturvedi N, Bandinelli S, Mangili R, Penno G, Rottiers RE, Fuller JH: Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int 60:219-227, 2001
Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS: Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348:2285-2293, 2003
Hadjadj S, Duly-Bouhanick B, Bekherraz A, Brldoux F, Gallois Y, Mauco G, Ebran J, Marre M: Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes. Diabetes Metab 30:43-51, 2004
Chowdhury TA, Dyer PH, Kumar S, Gibson SP, Rowe BR, Davies SJ, Marshall SM, Morris PJ, Gill GV, Feeney S, Maxwell P, Savage D, Boulton AJM, Todd JA, Dunger D, Barnett AH, Bain SC: Association of Apolipoprotein E2 allele with diabetic nephropathy in Caucasian subjects with IDDM. Diabetes 47:278-280, 1998
Onuma T, Laffel LMB, Angelico MC, Krolewski AS: Apolipoprotein E genotypes and risk of diabetic nephropathy. J Am Soc Nephrol 7:1075-1078, 1996
Fumeron F, Aubert R, Siddiq A, Betoulle D, Pean F, Hadjadj S, Tichet J, Wilpart E, Chesnier MC, Balkau B, Froguel P, Marre M: Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the Epidemiologic Data on the Insulin Resistance Syndrome prospective study. Diabetes 53:1150-1157, 2004